World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
44
Citations
9056
World Ranking
4762
National Ranking
208

Mauro S. Malnati publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Mauro S. Malnati sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 117 publications — 6th percentile

6% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Mauro S. Malnati D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Mauro S. Malnati sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 44 D-Index — 4th percentile

4% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Mauro S. Malnati is affiliated with Vita-Salute San Raffaele University in Italy and conducts research primarily within the field of Medicine, with a focus on Immunology, Surgery, Genetics, Infectious Diseases, and Molecular Biology.

The scientist's recent publications cover a range of topics, including pancreatic function, diabetes, immune cell function, and SARS-CoV-2 research. Some notable papers include:

  • "Antioxidant Activity with Increased Endogenous Levels of Vitamin C, E and A Following Dietary Supplementation with a Combination of Glutathione and Resveratrol Precursors" (2020, Nutrients)
  • "Profiling Antibody Response Patterns in COVID-19: Spike S1-Reactive IgA Signature in the Evolution of SARS-CoV-2 Infection" (2021, Frontiers in Immunology)
  • "Engineering of immune checkpoints B7-H3 and CD155 enhances immune compatibility of MHC-I−/− iPSCs for β cell replacement" (2022, Cell Reports)
  • "The longitudinal characterization of immune responses in COVID-19 patients reveals novel prognostic signatures for disease severity, patients' survival and long COVID" (2024, Frontiers in Immunology)
  • "A fast and reliable method for detecting SNP rs67384697 (Hsa-miR-148a binding site) by a single run of allele-specific real-time PCR" (2020, HLA)

Mauro S. Malnati frequently collaborates with several researchers, reflecting interdisciplinary and team-based approaches in their research. Frequent coauthors include:

  • Raniero Chimienti
  • Lorenzo Piemonti
  • Valeria Sordi
  • Gabriel Siracusano
  • F. Deambrogio

The scientist publishes mainly in venues such as Cytotherapy, Frontiers in Immunology, Transplantation, Cell Reports, and Nutrients, indicating involvement with both clinical and basic biomedical research communities.

The main topics of Mauro S. Malnati's research include:

  • Pancreatic function and diabetes
  • Diabetes and associated disorders
  • Immune Cell Function and Interaction
  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • Genomics, phytochemicals, and oxidative stress
  • Sirtuins and Resveratrol in Medicine

Best Publications

  • In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression.

    Gabriella Scarlatti;Eleonora Tresoldi;Åsa Björndal;Robert Fredriksson

  • Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains

    Nicolai Wagtmann;Roberto Biassoni;Claudia Cantoni;Simonetta Verdiani

  • CD46 is a cellular receptor for human herpesvirus 6.

    Fabio Santoro;Paul E Kennedy;Giuseppe Locatelli;Mauro S Malnati

  • Classification of HHV-6A and HHV-6B as distinct viruses.

    Dharam Ablashi;Henri Agut;Roberto Alvarez-Lafuente;Duncan A. Clark

  • Peptide Specificity in the Recognition of MHC Class I by Natural Killer Cell Clones

    Mauro S. Malnati;Marta Peruzzi;Kenneth C. Parker;William E. Biddison

  • Induction of CD4 and susceptibility to HIV-1 infection in human CD8+ T lymphocytes by human herpesvirus 6.

    Paolo Lusso;Andrea De Maria;Mauro Malnati;Franco Lori

  • Processing pathways for presentation of cytosolic antigen to MHC class II-restricted T cells.

    Mauro S. Malnati;Merce Marti;Timothy LaVaute;Dolores Jaraquemada

  • Additional evidence that pityriasis rosea is associated with reactivation of human herpesvirus-6 and -7.

    Francesco Broccolo;Francesco Drago;Anna M. Careddu;Chiara Foglieni

  • Infection of natural killer cells by human herpesvirus 6.

    Paolo Lusso;Mauro S. Malnati;Alfredo Garzino-Demo;Richard W. Crowley

  • A universal real-time PCR assay for the quantification of group-M HIV-1 proviral load.

    Mauro S Malnati;Gabriella Scarlatti;Francesca Gatto;Francesca Salvatori

  • Real-time quantitative PCR for human herpesvirus 6 DNA.

    Giuseppe Locatelli;Fabio Santoro;Fabrizio Veglia;T. Alberto Gobbi

  • Peptide sequence requirements for the recognition of HLA-B*2705 by specific natural killer cells.

    Marta Peruzzi;Kenneth C. Parker;Eric O. Long;Mauro S. Malnati

  • Productive infection of CD4+ and CD8+ mature human T cell populations and clones by human herpesvirus 6. Transcriptional down-regulation of CD3.

    P Lusso;M Malnati;A De Maria;C Balotta

  • Antigen-driven C–C Chemokine-mediated HIV-1 Suppression by CD4+ T Cells from Exposed Uninfected Individuals Expressing the Wild-type CCR-5 Allele

    Lucinda Furci;Gabriella Scarlatti;Samuele Burastero;Giuseppe Tambussi

  • Physical and functional independency of p70 and p58 natural killer (NK) cell receptors for HLA class I: their role in the definition of different groups of alloreactive NK cell clones

    M Vitale;S Sivori;D Pende;R Augugliaro

  • Efficient cDNA expression vectors for stable and transient expression of HLA-DR in transfected fibroblast and lymphoid cells.

    E. O. Long;S. Rosen-Bronson;S. Rosen-Bronson;David R Karp;David R Karp;M. Malnati;M. Malnati

  • Two processing pathways for the MHC class II-restricted presentation of exogenous influenza virus antigen.

    Valérie Pinet;Mauro S. Malnati;Eric O. Long

  • International network for comparison of HIV neutralization assays: the NeutNet report.

    Eva Maria Fenyö;Alan Heath;Stefania Dispinseri;Harvey Holmes

  • Specific lysis of allogeneic cells after activation of CD3- lymphocytes in mixed lymphocyte culture.

    E Ciccone;O Viale;D Pende;M Malnati

  • Infection of gamma/delta T lymphocytes by human herpesvirus 6: transcriptional induction of CD4 and susceptibility to HIV infection.

    Paolo Lusso;Alfredo Garzino-Demo;Richard W. Crowley;Mauro S. Malnati

  • Rapid Diagnosis of Mycobacterial Infections and Quantitation of Mycobacterium tuberculosis Load by Two Real-Time Calibrated PCR Assays

    Francesco Broccolo;Paolo Scarpellini;Giuseppe Locatelli;Anna Zingale

Frequent Co-Authors

Paolo Lusso
Paolo Lusso National Institutes of Health
Gabriella Scarlatti
Gabriella Scarlatti Vita-Salute San Raffaele University
Giuseppe Tambussi
Giuseppe Tambussi Vita-Salute San Raffaele University
Guido Poli
Guido Poli Vita-Salute San Raffaele University
Roberto Biassoni
Roberto Biassoni Istituto Giannina Gaslini
Adriano Lazzarin
Adriano Lazzarin Vita-Salute San Raffaele University
Eric O. Long
Eric O. Long National Institutes of Health
Barbara Ensoli
Barbara Ensoli Istituto Superiore di Sanità
Antonio G. Siccardi
Antonio G. Siccardi IRCCS Ospedale San Raffaele
Lucia Lopalco
Lucia Lopalco Vita-Salute San Raffaele University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing Immunology in the USA opens doors to diverse career paths in healthcare and research. For those interested in clinical practice, transitioning from a Family Nurse Practitioner (FNP) to an Acute Care Nurse Practitioner (ACNP) can provide advanced skills to manage acute and critical care patients. Exploring how to fnp to acnp transitions can help tailor your clinical focus toward immunology-related specialties.

If you are aiming to fast-track your nursing education, accelerated programs offer a practical solution. Many students benefit from enrolling in a nurse practitioner accelerated program to gain advanced practice roles more quickly, integrating immunological concepts into patient care.

For those without a nursing background, starting with online adn programs for non nurses provides foundational knowledge and clinical skills, opening pathways into nursing specialties that intersect with immunological science.

Additionally, 12-month accelerated options offer an expedited route to become a registered nurse. Researching 12-month accelerated nursing programs allows prospective students to find programs that balance accessibility and rigorous training to quickly enter the healthcare workforce with a strong emphasis on immunology-related healthcare.

Best Scientists Citing Mauro S. Malnati

Trending Scientists

Recently Published Articles